MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce the appointment of veteran healthcare industry leader Jeffrey Morris as Vice President of Sales and Marketing.

安大略省密西沙加-（商业线）-MedX Health Corp.（“MedX”或“公司”）（TSXV:MDX），远程皮肤病学全球领导者，很高兴宣布任命退伍军人医疗保健行业领导者杰弗里莫里斯担任销售和营销副总裁。

With over 20 years of experience, Mr. Morris has worked for some of the most recognized global healthcare and pharmaceutical brands such as Pfizer Inc., Boehringer-Ingelheim Canada, Merck Canada Inc., Novartis Vaccines and Sanofi Pasteur. Mr. Morris brings a strong track record of establishing new territory clinic and physician relationships, implementing and leading large-scale sales and marketing teams and driving sales results..

凭借20多年的经验，Morris先生一直为一些最知名的全球医疗保健和制药品牌工作，如辉瑞公司，加拿大勃林格殷格翰公司，默克加拿大公司，诺华疫苗公司和赛诺菲巴斯德公司。莫里斯先生为建立新的领域诊所和医生关系，实施和领导大规模销售和营销团队以及推动销售成果带来了坚实的记录。。

'I am honoured to be joining MedX Health at this pivotal stage of growth for the company,' said Jeffrey. 'With our unique teledermatology technology platform, I look forward to establishing MedX as an industry leader.'

“我很荣幸在公司成长的关键阶段加入MedX Health，”杰弗里说凭借我们独特的远程皮肤病学技术平台，我期待建立MedX作为行业领导者

'We are very pleased to have Jeffrey join our team,' said Stephen Lockyer, Chief Executive Officer of MedX Health. 'We searched for a recognized health-care executive in the diagnostics space, a leader with proven sales and marketing expertise, one who is results driven and up to the task of building a strong team at MedX.

“我们非常高兴让Jeffrey加入我们的团队，”MedX Health首席执行官Stephen Lockyer说我们在诊断领域寻找一位公认的医疗保健执行官，他是一位具有良好销售和营销专业知识的领导者，他是结果驱动的，并且致力于在MedX建立一支强大的团队。

Jeffrey met all of those criteria, and we are glad to have him aboard. He will be a critical part of our success.'.

杰弗里符合所有这些标准，我们很高兴让他进来。他将是我们成功的关键部分。

MedX’s leading telemedicine platform allows health-care practitioners to quickly and accurately assess suspicious moles, lesions and other skin conditions via its image-capture technology, SIAscopy®, and its secure, cloud-based patient management system, DermSecure®, which transmits and stores patient data throughout the assessment process.

MedX领先的远程医疗平台使医疗保健从业人员能够通过其图像采集技术SIAscopy®及其安全的基于云的患者管理系统DermSecure®快速准确地评估可疑痣，病变和其他皮肤状况，该系统可传输和存储患者数据整个评估过程。

MedX’s SIAscopy® is the only technology that captures five images, including four spectrophotometric images 2mm below the skin’s surface. Teledermatology, is a subspecialty of dermatology that offers safe and effective virtual patient assessment and diagnosis at a distance, eliminating the need for in-person appointments..

MedX的SIAscopy®是唯一捕获五幅图像的技术，包括皮肤表面以下2mm的四幅分光光度图像。远程皮肤病学是皮肤病学的一个子专业，可远距离提供安全有效的虚拟患者评估和诊断，无需亲自预约。。

About MedX Health Corp.:

关于MedX健康公司：

MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility.

MedX总部设在加拿大安大略省，是一家专注于皮肤健康的领先医疗设备和软件公司，利用其SIAscopy®技术在DermSafe®远程医疗平台上实现SIAscopy®。SIAscopy®还嵌入其产品SIAMETRICS®，SIMSYS®和MoleMate®，MedX在其ISO 13485认证设施中生产。

SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds.

SIAMETRICS®，SIMSYS®和MoleMate®包括手持设备，这些设备使用光和其汇出技术以无痛，无创的方式在可疑痣和病变下方最多2 mm处观察，然后使用其软件为医生和皮肤科医生创建实时图像，在几秒钟内评估所有类型的痣或病变。

These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil and Turkey. Visit https://medxhealth.com..

这些产品经加拿大卫生部，美国食品和药物管理局，治疗用品管理局和ConformitéEuropéenne批准，可在加拿大，美国，澳大利亚，新西兰，欧盟，巴西和土耳其使用。访问https://medxhealth.com..

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

TSX Venture Exchange及其监管服务提供商（因为该术语在TSX Venture Exchange的政策中定义）均不对本版本的充分性或准确性承担责任。

This Media Release may contain forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties.

本媒体发布可能包含前瞻性声明，反映公司目前对未来事件的期望。前瞻性陈述涉及风险和不确定性。